BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2606 related articles for article (PubMed ID: 15604013)

  • 41. Human IgG1 Cgamma1 domain is crucial for the bioactivity of the engineered anti-CD20 antibodies.
    Geng S; Feng J; Li Y; Kang X; Sun Y; Gu X; Huang Y; Chang H; Shen BF
    Cell Mol Immunol; 2007 Apr; 4(2):121-5. PubMed ID: 17484806
    [TBL] [Abstract][Full Text] [Related]  

  • 42. One-step expression and purification of single-chain variable antibody fragment using an improved hexahistidine tag phagemid vector.
    Zhao Q; Chan YW; Lee SS; Cheung WT
    Protein Expr Purif; 2009 Dec; 68(2):190-5. PubMed ID: 19683057
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Rapid isolation of single-chain antibodies by phage display technology directed against one of the most potent marine toxins: Palytoxin.
    Garet E; Cabado AG; Vieites JM; González-Fernández A
    Toxicon; 2010 Jul; 55(8):1519-26. PubMed ID: 20223256
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Construction and characterization of recombinant single-chain variable fragment antibodies against Toxoplasma gondii MIC2 protein.
    Hoe LN; Wan KL; Nathan S
    Parasitology; 2005 Dec; 131(Pt 6):759-68. PubMed ID: 16336729
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intracellular antibody capture technology: application to selection of intracellular antibodies recognising the BCR-ABL oncogenic protein.
    Tse E; Lobato MN; Forster A; Tanaka T; Chung GT; Rabbitts TH
    J Mol Biol; 2002 Mar; 317(1):85-94. PubMed ID: 11916380
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Production of soluble ScFvs with C-terminal-free thiol for site-specific conjugation or stable dimeric ScFvs on demand.
    Albrecht H; Burke PA; Natarajan A; Xiong CY; Kalicinsky M; DeNardo GL; DeNardo SJ
    Bioconjug Chem; 2004; 15(1):16-26. PubMed ID: 14733579
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Guided selection of a pan carcinoma specific antibody reveals similar binding characteristics yet structural divergence between the original murine antibody and its human equivalent.
    Beiboer SH; Reurs A; Roovers RC; Arends JW; Whitelegg NR; Rees AR; Hoogenboom HR
    J Mol Biol; 2000 Feb; 296(3):833-49. PubMed ID: 10677285
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Human single-chain Fv antibodies to MUC1 core peptide selected from phage display libraries recognize unique epitopes and predominantly bind adenocarcinoma.
    Henderikx P; Kandilogiannaki M; Petrarca C; von Mensdorff-Pouilly S; Hilgers JH; Krambovitis E; Arends JW; Hoogenboom HR
    Cancer Res; 1998 Oct; 58(19):4324-32. PubMed ID: 9766660
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Construction and molecular characterization of mouse single-chain variable fragment antibodies against Burkholderia mallei and Burkholderia pseudomallei.
    Kim HS; Tsai S; Zou N; Lo SC; Wear DJ; Izadjoo MJ
    J Immunol Methods; 2011 Feb; 365(1-2):101-9. PubMed ID: 21172353
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Development of a hyperimmune anti-MUC-1 single chain antibody fragments phage display library for targeting breast cancer.
    Winthrop MD; DeNardo SJ; DeNardo GL
    Clin Cancer Res; 1999 Oct; 5(10 Suppl):3088s-3094s. PubMed ID: 10541348
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Human antibodies with sub-nanomolar affinities isolated from a large non-immunized phage display library.
    Vaughan TJ; Williams AJ; Pritchard K; Osbourn JK; Pope AR; Earnshaw JC; McCafferty J; Hodits RA; Wilton J; Johnson KS
    Nat Biotechnol; 1996 Mar; 14(3):309-14. PubMed ID: 9630891
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Characterization of human variable domain antibody fragments against the U1 RNA-associated A protein, selected from a synthetic and patient-derived combinatorial V gene library.
    de Wildt RM; Finnern R; Ouwehand WH; Griffiths AD; van Venrooij WJ; Hoet RM
    Eur J Immunol; 1996 Mar; 26(3):629-39. PubMed ID: 8605931
    [TBL] [Abstract][Full Text] [Related]  

  • 53. pSKAP/S: An expression vector for the production of single-chain Fv alkaline phosphatase fusion proteins.
    Griep RA; van Twisk C; Kerschbaumer RJ; Harper K; Torrance L; Himmler G; van der Wolf JM; Schots A
    Protein Expr Purif; 1999 Jun; 16(1):63-9. PubMed ID: 10336861
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The inhibition of lung cancer cell growth by intracellular immunization with LC-1 ScFv.
    Chen L; Li G; Tang L; Wang J; Ge XR
    Cell Res; 2002 Mar; 12(1):47-54. PubMed ID: 11942410
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antibody phage libraries for the next generation of tumor targeting radioimmunotherapeutics.
    DeNardo SJ; DeNardo GL; DeNardo DG; Xiong CY; Shi XB; Winthrop MD; Kroger LA; Carter P
    Clin Cancer Res; 1999 Oct; 5(10 Suppl):3213s-3218s. PubMed ID: 10541366
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cloning antifungal single chain fragment variable antibodies by phage display and competitive panning elution.
    Krishnaswamy S; Kabir ME; Miyamoto M; Furuichi Y; Komiyama T
    Anal Biochem; 2009 Dec; 395(1):16-24. PubMed ID: 19665444
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Establishment of hapten-specific monoclonal avian IgY by conversion of antibody fragments obtained from combinatorial libraries.
    Deckers S; Braren I; Greunke K; Meyer N; Rühl D; Bredehorst R; Spillner E
    Biotechnol Appl Biochem; 2009 Jan; 52(Pt 1):79-87. PubMed ID: 18627355
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Multivalent scFv display of phagemid repertoires for the selection of carbohydrate-specific antibodies and its application to the Thomsen-Friedenreich antigen.
    Ravn P; Danielczyk A; Jensen KB; Kristensen P; Christensen PA; Larsen M; Karsten U; Goletz S
    J Mol Biol; 2004 Oct; 343(4):985-96. PubMed ID: 15476815
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Production and characterization of a human monoclonal anti-idiotype to anti-ribosomal P antibodies.
    Zhang W; Reichlin M
    Clin Immunol; 2005 Feb; 114(2):130-6. PubMed ID: 15639646
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Anti-VEGFR-2 scFvs for cell isolation. Single-chain antibodies recognizing the human vascular endothelial growth factor receptor-2 (VEGFR-2/flk-1) on the surface of primary endothelial cells and preselected CD34+ cells from cord blood.
    Böldicke T; Tesar M; Griesel C; Rohde M; Gröne HJ; Waltenberger J; Kollet O; Lapidot T; Yayon A; Weich H
    Stem Cells; 2001; 19(1):24-36. PubMed ID: 11209088
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 131.